Asano Toshihiko, Adachi Yoshikazu
Research Center, Astellas Pharma Inc., Ibaraki, Japan.
J Vet Med Sci. 2006 Jun;68(6):555-60. doi: 10.1292/jvms.68.555.
Griseoviridin, a known antibiotic produced by Streptomyces cacaoi subsp. cacaoi, was found to be active against Brachyspira hyodysenteriae--the bacterium causing swine dysentery. An in vitro synergism is observed when it is used in combination with viridogrisein--a simultaneously produced antibiotic. In mouse experiments, the effect of griseoviridin alone was less than that of lincomycin--a commercially available swine dysentery medication. However, a 1:1 mixture of griseoviridin and viridogrisein revealed a noticeable synergistic effect. In an evaluation using pigs artificially infected with B. hyodysenteriae, a large difference was not observed between the effect of griseoviridin alone and that in combination with viridogrisein. Nevertheless, griseoviridin alone exhibited a therapeutic effect superior to that of lincomycin.
灰绿霉素是由可可链霉菌可可亚种产生的一种已知抗生素,发现它对引起猪痢疾的猪痢疾短螺旋体具有活性。当它与同时产生的抗生素绿灰霉素联合使用时,可观察到体外协同作用。在小鼠实验中,单独使用灰绿霉素的效果不如市售的猪痢疾药物林可霉素。然而,灰绿霉素和绿灰霉素的1:1混合物显示出明显的协同作用。在对人工感染猪痢疾短螺旋体的猪进行的评估中,单独使用灰绿霉素的效果与与绿灰霉素联合使用的效果之间没有观察到很大差异。尽管如此,单独使用灰绿霉素的治疗效果优于林可霉素。